Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Cancer researcher Joan Massagué wins the BBVA Foundation Frontiers of Knowledge Award in Biomedicine

27.01.2009
The BBVA Foundation Frontiers of Knowledge Award in the Biomedicine category has gone in this inaugural edition to cancer researcher Joan Massagué i Solé (Barcelona, 1953), Spain’s most internationally cited working scientist.

Massagué’s research has elucidated fundamental processes that control cell division and identified genes playing a key role in tumor generation and metastasis. This is work “with great potential for clinical application”, in the words of the jury chaired by Nobel laureate in Physiology and Medicine, Torsten Wiesel.

The BBVA Foundation Frontiers of Knowledge Awards seek to recognize and encourage world-class research at international level, and can be considered second only to the Nobel Prize in their monetary amount, an annual 3.2 million euros, and the breadth of the scientific and artistic areas covered.

The awards, organized in partnership with Spain’s National Research Council (CSIC), take in eight categories carrying a cash prize of 400,000 euros each. The Biomedicine award, the third to be decided, is to honor contributions which significantly advance the stock of knowledge in this area for reasons of their importance and originality.

“We are striving to move forward the frontiers of oncology”
Massagué’s first remarks on receiving the news were: “I am even more delighted given the ambitiousness of these awards, as evidenced by the stature of the winners in the two categories previously decided. And I am proud that an international initiative to recognize knowledge as future capital comes from an institution, the BBVA Foundation, of Spanish nationality”.

On the merits that earned him this award, he explains: “In a field as wide as Biomedicine, the fact that the jury has singled out my work is an encouragement to my group and to other researchers in oncology. We are striving to move forward the frontiers of oncology, starting from the study of very basic aspects like cell biology and behavior, that are perhaps abstruse for most people, in order to address others as concrete as metastasis, so that what yesterday seemed impossible is today a tentative promise and may in a few years’ time become a solution”.

Joan Massagué is Chairman of the Cancer Biology and Genetics Program at the Sloan-Kettering Institute in New York, where he has pursued most of his scientific career. He is also a researcher at the Howard Hughes Medical Institute and Adjunct Director of the Institute for Biomedical Research (IRB Barcelona). He has more than 340 publications to his name in leading scientific journals, which have been cited more than 62,000 times.

Joan Massagué’s research stands out for the identification and characterization of the TGF-beta protein (transforming growth factor beta). This protein belongs to a large family of factors that regulate the cell division process. It is essential for the organism’s normal development but is also implicated in disease processes such as malformations and cancer.

Great potential for clinical application

The jury’s citation reads as follows: “The BBVA Foundation Frontiers of Knowledge Award in Biomedicine corresponding to the year 2008 has been conferred upon Dr. Joan Massagué for elucidating one of the fundamental processes that control cell division, namely, the machinery that conveys the growth inhibitory signal of TGF-beta from the cell membrane to the nucleus. Many of the components of this signaling transduction pathway have been identified and functionally characterized by Dr. Massagué. The TGF-beta pathway is crucial for the development of all animals, and when disrupted, contributes to diseases such as cancer. Massagué and colleagues have also developed novel approaches to identify genes involved in organ-specific metastasis. These studies have considerably increased the understanding of metastasis and have great potential for clinical application, given that 90 percent of cancer-related deaths are due to this invasive process”.

The jury in this inaugural edition of the Frontiers of Knowledge Awards, Biomedicine category, was chaired by Torsten Wiesel, Nobel Prize in Physiology and Medicine, and formed by Angelika Schnieke, Technical University of Munich (Germany), an expert on cloning and second author of the ‘Dolly’ paper; Bruce Whitelaw, a leading expert in transgenic animals, Roslin Institute (United Kingdom); Dario Alessi of the Scottish Institute for Cell Signalling (United Kingdom); Robin Lovell-Badge, of the National Institute for Medical Research (United Kingdom); Josep Baselga, oncologist in the Research Institute of Vall d’Hebron Hospital, Barcelona; and Juan Modolell, Severo Ochoa Molecular Biology Center, Madrid, holder of the ‘Santiago Ramón y Cajal’ National Research Prize in Biology.

Biomedicine is the third award to be decided in this first edition of the BBVA Foundation Frontiers of Knowledge Awards. The Climate Change award was granted to U.S. scientist Wallace S. Broecker, who predicted climate warming due to human activity three decades ago. The award in the Development Cooperation went to the Abdul Latif Jameel Poverty Action Lab (J-PAL) at the Massachusetts Institute of Technology (MIT).

The BBVA Foundation supports knowledge generation, scientific research and the promotion of culture, relaying the results of its work to society at large. This effort materializes in research projects, human capital investment, specialization courses, grants and awards. Among the Foundation’s preferred areas of activity are basic sciences, biomedicine, ecology and conservation biology, the social sciences and literary and musical creation.

Javier Fernández | alfa
Further information:
http://www.fbbva.es/TLFU/tlfu/ing/noticias/fichanoticia/index.jsp?codigo=448

More articles from Awards Funding:

nachricht The quest for the oldest ice on Earth
14.11.2016 | Alfred-Wegener-Institut, Helmholtz-Zentrum für Polar- und Meeresforschung

nachricht Empa Innovation Award for new flame retardant
09.11.2016 | Empa - Eidgenössische Materialprüfungs- und Forschungsanstalt

All articles from Awards Funding >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Electron highway inside crystal

Physicists of the University of Würzburg have made an astonishing discovery in a specific type of topological insulators. The effect is due to the structure of the materials used. The researchers have now published their work in the journal Science.

Topological insulators are currently the hot topic in physics according to the newspaper Neue Zürcher Zeitung. Only a few weeks ago, their importance was...

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

Researchers identify potentially druggable mutant p53 proteins that promote cancer growth

09.12.2016 | Life Sciences

Scientists produce a new roadmap for guiding development & conservation in the Amazon

09.12.2016 | Ecology, The Environment and Conservation

Satellites, airport visibility readings shed light on troops' exposure to air pollution

09.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>